Form EFFECT Tempest Therapeutics,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | October 1, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- InvestorNewsBreaks – AZIO AI Holdings, Inc. (NASDAQ: AZIO) Featured in NetworkNewsAudio Release on Contracted Capacity as Key AI Infrastructure Metric
- French Parliamentarians Propose Exit Tax for Crypto Owners
- SpartanX Appoints Erik Hardy as Chief Executive Officer and Launches Vendor Management, Expanding Its Autonomous Offensive Security Platform
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share